Patent ID: 9107954
Filing Date: 2015-08-18
Classification: A61K,A61P,C07D

Abstract:
1. A method of treating neuroAIDS in a subject in need thereof, comprising administering to said subject a therapeutically effective amount of at least one bivalent ligand of Formula I, wherein R R R R6 and R7 may be the same or different, and are independently selected from: H; halogen; a saturated or unsaturated, branched or unbranched, substituted or unsubstituted carbon group or chain comprising from 1-20 carbon atoms; a cyclic or polycyclic saturated or unsaturated homo- or heterocyclic ring system comprising 1, 2, 3, 4, or more rings with from 3 to 7 atoms per ring in the system, which may be fused to one or more atoms of the hexane ring; and a heteroatomic group; and X=a branched or unbranched, saturated or unsaturated carbon chain comprising from 1-20 carbon atoms, and may include a heteroatomic group; as well as salts, hydrates, protonated and unprotonated and stereoisomeric forms thereof.